Exten Industries reported today that its wholly owned subsidiary,
MultiCell Technologies, a liver cell engineering and research
organisation in Warwick, US has just signed a nonexclusive license
agreement with a major pharmaceutical...
High Content Screening company Cellomics announced today that the
Canadian Intellectual Property Office has issued Cellomics'
Canadian Patent No. 2,328,194 entitled 'A System for Cell-Based
In relation to recent media comments relating to its
commercialisation discussions UK company GW Pharmaceuticals said in
a statement this week that it has consistently stated its
commercial strategy 'to be to enter into partnerships...
US Valentis announced that its wholly-owned subsidiary, PolyMASC
Pharmaceuticals, has received a favourable ruling from the Japanese
Patent Office in regard to patent invalidation proceedings brought
by ALZA Corporation, a unit of...
Canadian drug development company Ecopia BioSciences on Monday
announced that it had filed patent applications for the first two
novel compounds using its proprietary drug discovery platform -
suggesting investments by the company...
As in-licensing opportunities are reduced and competition for
market share in Japan increases with the rising penetration of
western pharma companies, domestic mid-cap players must alter their
strategies to remain independent, writes...
London zoo was the setting last week for UK inspection body Select
QA to formally receive certification from the United Kingdom
Accreditation Service, involving the company in a new scheme for
the food packaging industry.
Alcan Pharma Center, a US division of flexible packaging unit Alcan
Packaging, has installed a new four colour Rotomec 3000-5 ES
gravure printing press, with in-line coating from UK company Valmet
US company Molecular Devices, a supplier of bioanalytical
measurement systems, announced its revenues and earnings for the
quarter and year ended 31 December, 2002. Revenues for the fourth
quarter of 2002 were a healthy $30.2 million,...